Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
About half of patients who respond to acute-phase cognitive therapy (CT) for major depressive disorder (MDD) will relapse/recur within 2 years; continuation-phase CT lowers this risk. We analyzed demographic, clinical, cognitive, social-interpersonal, and personality variables to clarify which patients continuation-phase CT helps to avoid relapse and recurrence and achieve remission and recovery. Participants had recurrent MDD, responded to acute-phase CT, were randomized to 8 months of continuation-phase CT (n = 41) or assessment control (n = 43), and were assessed 16 additional months (Jarrett, Kraft, Doyle et al., 2001). Consistent with an underlying risk-reduction model, continuation-phase CT was helpful for responders to acute-phase CT with greater risk and/or dysfunction as follows: Younger patients with earlier MDD onset who displayed greater dysfunctional attitudes and lower self-efficacy; personality traits suggesting low positive activation (e.g., reduced energy, enthusiasm, gregariousness); and transiently elevated depressive symptoms late in acute-phase CT and residual symptoms after acute-phase CT response. We emphasize the need for replication of these results before clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Self-Efficacy Scale: Construction and Validation
Sherer, M., Maddux, J. E., Mercandante, B., Prentice-Dunn, S., Jacobs, B., & Rogers, R. W. (1982) · Psychological Reports · doi:10.2466/pr0.1982.51.2.663 · Cited by 4,028
Development and validation of the working alliance inventory
Horvath, A. O., & Greenberg, L. S. (1989) · Journal of Counseling Psychology · doi:10.1037//0022-0167.36.2.223 · Cited by 3,520
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Self-citationInventory of interpersonal problems: Psychometric properties and clinical applications.
Horowitz, L. M., Rosenberg, S. E., Baer, B. A., Ureño, G., & Villaseñor, V. S. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.885 · Cited by 2,026 · cited 1×
“The scale correlates appropriately with measures of psychiatric symptoms, and decreases with psychotherapy (Horowitz et al., 1988).”
BackgroundFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“, 2007 for types) is to decrease relapse and recurrence (defined as having a major depressive episode before and after recovery, respectively; Frank et al., 1991), and to increase remission and recovery (defined”
BackgroundAssessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782
Temperament, personality, and the mood and anxiety disorders.
Clark, L. A., Watson, D., & Mineka, S. (1994) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.103.1.103 · Cited by 1,685
Self-citationKeller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607 · cited 1×
“, 2009) intentionally are more rigorous than in most previous research (e.g., low symptoms at the end of acute-phase CT, DeRubeis et al., 2005; Dimidjian et al., 2006; absence of a major depressive episode during follow-up, Dobson et al., 2008; Hollon, DeRubeis, et al., 2005; Hollon, Jarrett, et al., 2005).”
MethodMa, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390
Risk for recurrence in depression
Burcusa, S. L., & Iacono, W. G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.02.005 · Cited by 1,023
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989
Prevention of Relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.417 · Cited by 735 · cited 2×
“, 2009) intentionally are more rigorous than in most previous research (e.g., low symptoms at the end of acute-phase CT, DeRubeis et al., 2005; Dimidjian et al., 2006; absence of a major depressive episode during follow-up, Dobson et al., 2008; Hollon et al., 2005).”
BackgroundMethodReport by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707 · cited 2×
“Specifically, our definitions of remission and recovery capture outcomes that arguably are more important to patients and their families because they require a longer duration (Rush et al., 2006), and because few to no symptoms preclude significantly fluctuating and residual symptoms of depression that produce substan…”
BackgroundA guide to treatments that work
(2015) · Oxford Clinical Psychology · doi:10.1093/med:psych/9780195304145.001.0001 · Cited by 647
Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593
Dobson, K. S., Hollon, S. D., Dimidjian, S., Schmaling, K. B., Kohlenberg, R. J., Gallop, R. J., Rizvi, S. L., Gollan, J. K., Dunner, D. L., & Jacobson, N. S. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.468 · Cited by 560 · cited 2×
“, 2008; Vittengl, Clark, Dunn, & Jarrett, 2007), a rate comparable to continued pharmacotherapy (Dobson et al., 2008; Hollon, Stewart, & Strunk, 2006).”
BackgroundVittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.475 · Cited by 551 · cited 3×
“20 is roughly the average effect of continuation-phase CT versus non-active control on relapse/recurrence at the end of treatment (Vittengl et al., 2007).”
BackgroundInfluentialSelf-citationSocial adjustment by self-report in a community sample and in psychiatric outpatients
WEISSMAN, M. M., PRUSOFF, B. A., THOMPSON, W. D., HARDING, P. S., & MYERS, J. K. (1978) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197805000-00002 · Cited by 537
Prevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Enduring Effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety
Hollon, S. D., Stewart, M. O., & Strunk, D. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190044 · Cited by 466
Six-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1872 · Cited by 392 · cited 1×
“Treatments derived from these five models of post-acutephase CT have been shown to decrease relapse or recurrence of major depression (Bockting et al., 2005; Fava et al., 2004; Jarrett et al., 2001; Ma & Teasdale, 2004; Paykel et al., 1999; Teasdale et al., 2000).”
MethodHow does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial.
Teasdale, J. D., Scott, J., Moore, R. G., Hayhurst, H., Pope, M., & Paykel, E. S. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.3.347 · Cited by 269
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1046 · Cited by 252 · cited 1×
“Also related to residual symptoms, unstable remission involves elevated depressive symptoms late in acute-phase treatment and predicts relapse (Thase et al., 1992; Jarrett et al., 2001).”
BackgroundBockting, C. L. H., DELTA Study Group, Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.4.647 · Cited by 249 · cited 4×
“, 2000) or 5 (Bockting et al., 2005) prior major depressive episodes, but not for those with fewer episodes.”
BackgroundMethodResultInfluentialThe concept of recovery in major depression
FAVA, G. A., RUINI, C., & BELAISE, C. (2007) · Psychological Medicine · doi:10.1017/s0033291706008981 · Cited by 230 · cited 1×
“Our results both replicate previous findings of risks for poor outcomes after response to acute-phase treatment (e.g., early age of MDD onset, poor social-interpersonal and cognitive functioning, residual symptoms, personality pathology; Burcusa & Iacono, 2006; Fava et al., 2007) and also add to the literature by iden…”
ResultComparison of alternative models for personality disorders
MOREY, L. C., HOPWOOD, C. J., GUNDERSON, J. G., SKODOL, A. E., SHEA, M. T., YEN, S., STOUT, R. L., ZANARINI, M. C., GRILO, C. M., SANISLOW, C. A., et al. (2007) · Psychological Medicine · doi:10.1017/s0033291706009482 · Cited by 204
Residual symptoms in depression
Fava, G. A., Fabbri, S., & Sonino, N. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00226-9 · Cited by 137
Six Months of Treatment for Depression: Outcome and Predictors of the Course of Illness
Mulder, R. T., Joyce, P. R., Frampton, C. M. A., Luty, S. E., & Sullivan, P. F. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.95 · Cited by 127
Ilardi, S. S., Craighead, W. E., & Evans, D. D. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.381 · Cited by 115
Jarrett, R. B., Vittengl, J. R., Doyle, K., & Clark, L. A. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.432 · Cited by 72 · cited 2×
“92 for the Self-Efficacy Scale total score used in the current analyses (Jarrett et al., 2007).”
MethodSelf-citationJarrett, R. B., & Thase, M. E. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.04.004 · Cited by 51
Self-citation
Cited by
A systematic review of personality trait change through intervention.
Roberts, B. W., Luo, J., Briley, D. A., Chow, P. I., Su, R., & Hill, P. L. (2017) · Psychological Bulletin · doi:10.1037/bul0000088 · Cited by 1,047
Dunn, B. D. (2012) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.1799 · Cited by 168
Ebert, D. D., Gollwitzer, M., Riper, H., Cuijpers, P., Baumeister, H., & Berking, M. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2511 · Cited by 61
Jarrett, R. B., & Thase, M. E. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.04.004 · Cited by 51
Self-citationBrouwer, M. E., Williams, A. D., Kennis, M., Fu, Z., Klein, N. S., Cuijpers, P., & Bockting, C. L. H. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.101773 · Cited by 39
Metadata
- Authors
- Vittengl, J. R., Clark, L. A., & Jarrett, R. B.
- Venue
- Behaviour Research and Therapy
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 48
- Issue
- 6
- Pages
- 449-458
- ISSN
- 0005-7967 (ISSN-L)
- OpenAlex
- W2067740266
- Cited by
- 32
- References
- 32
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.